Home Page | Sponsors/Exhibits | Program | Registration | Abstracts | Social Events | Accommodations | Business Meetings | Contact
SYMPOSIA, LECTURES, AND SPECIAL INTEREST GROUP SESSIONS     Saturday Evening • Patient Safety & Quality Assurance Symposium • Residents' Symposium • Biobanking SIG Session • Informatics SIG Session • Education SIG Session     Sunday Evening • Junior Scientist Award Lecture • William Boyd Award Lecture • Guillermo Quinonez Seminar on the Medical Humanities SIG • International Health SIG – Assisting the Development of Pathology in Low Resource Nations     Monday Morning • Hematological Pathology Symposium • Canadian Society of Cytopathology Symposium and Kulcsar Lecture     Monday Afternoon • Dr. Cam Coady Slide Seminar: Dermatopathology     Tuesday Morning • Anatomical Pathology Symposium • Pediatric and Perinatal Symposium     Tuesday Afternoon • Advanced Diagnostics Symposium • Forensic Symposium • Neuropathology Symposium • Workshop on Media Relations • Exit Competencies in Pathology and Laboratory Medicine for Canadian Medical Graduates       CONFERENCE SPONSORS   PLATINUM                         SILVER             BRONZE	SYMPOSIA, LECTURES, AND SPECIAL INTEREST GROUP SESSIONS   SATURDAY, JULY 21   S2131 Patient Safety and Quality Assurance Symposium Saturday, 1700-1930 Chair: Diponkar Banerjee, PHSA Laboratories, Vancouver, British Columbia   Click here for Objectives of this symposium •  Recognize latent factors that contribute to failures in anatomic pathology processes; •  Describe patient and system outcomes secondary to failures in anatomic pathology processes; •  Use mitigation strategies to decrease the frequency and the severity of harm of anatomic pathology failures. ------------------------------------------- 1700-1800 Quality Management in Anatomic Pathology: Case Studies, Analysis and Outcomes Beverley A. Carter, Government of Newfoundland and Labrador, St. John’s, Newfoundland 1800-1900 Stephen Raab, Eastern Health Authority and Memorial University of Newfoundland, St. John’s, Newfoundland 1900-1930 Question and Answer Session with both speakers   Back to top     S2132 Residents' Symposium Saturday, 1800-1900 Chairs: Davinder Sidhu and Lik Hang Lee 1800-1900 Effective CV Creation for Pathology Residents Janet E. Soles, Managing Partner, Odgers Berndston 1900-2000 Dinner: Sky 360 at Calgary Tower   Back to top     G2141 Biobanking SIG Saturday, 2000-2200 Chair: Patricia Shaw, University Health Network, Toronto, Ontario   Back to top     G2142 Informatics SIG Saturday, 2000-2200 Chair: George Yousef, St. Michael’s Hospital, Toronto, Ontario   Digital Pathology Education Fantasy or Reality Aaron Pollett, Mount Sinai Hospital, Toronto, Ontario   Image Analysis in Routine Pathology Practice: Are We There Yet Christopher Naugler, Calgary Laboratory Services, Calgary, Alberta   Informatics in Pathology Research: The Bridge to the Future George M. Yousef, St. Michael’s Hospital, Toronto, Ontario   Back to top     G2143 Education SIG Saturday, 2000-2200 Chair: Jason Ford, Children’s and Women’s Health Centre of British Columbia, Vancouver, British Columbia   Back to top     SUNDAY, JULY 22   S2231 Junior Scientist Award Lecture Sunday, 1700-1745   Molecular Basis of Humoral Immunologic Rejection of Organ Transplants and Getting Ready for Molecular Precision Diagnostics for Transplants Banu Sis, University of Alberta Hospital, Edmonton, Alberta Click here for Objectives of this symposium At the end of the session, the participants will: •  Understand why and how immune system rejects transplanted organs; •  Understand clinical and pathological phenotypes of transplant rejection, with a focus on antibody – mediated (humoral) rejection; •  Understand molecular mechanisms of humoral rejection, current diagnostic approach, and new diagnostic opportunities towards a personalized precision diagnostics. -------------------------------------------   Back to top     S2232 William Boyd Award Lecture Sunday, 1745-1830   Going Viral Richard Hegele, University of Toronto and the Hospital for Sick Children, Toronto, Ontario Click here for Objectives of this symposium At the end of the session, the participants will be able to: •  Summarize evidence that the human lung is not a sterile environment; •  Explain the role of viral infections in the pathogenesis of asthma and COPD; •  Explain the process of viral receptor discovery and validation for human respiratory syncytial virus. -------------------------------------------   Back to top     G2241 Guillermo Quinonez Seminar on the Medical Humanities SIG Saturday, 2030-2230 Chair: Laurette Geldenhuys, QE II Health Sciences Centre, Halifax, Nova Scotia 2030-2130 Albert C. Broders’ Paradigm Shifts Involving the Prognostication and Definition of Cancer James R. Wright, University of Calgary/Alberta Health Services, Calgary, Alberta Click here for Objectives of this symposium At the end of the session, the participants will be able to: •  Examine the history of tumors grading and staging; •  Describe the history of the concept of carcinoma in situ; •  Explore the role of Albert C. Broders and others in these discoveries. ------------------------------------------- 2130-2230 No Baby – No Nation – A History of Pediatrics and Pediatric Laboratory Science Fergall Magee, IWK Health Centre, Halifax, Nova Scotia Click here for Objectives of this symposium At the end of the session, the participants will be able to: •  Appreciate the history childhood and children; •  Understand the changing approach to childhood disease from antiquity to modern times; •  Have an overview of the impact of pediatric laboratory science in improving health outcomes for children; •  Be aware of the threats to continued funding for pediatric health care in Canada. -------------------------------------------   Back to top     G2242 International Health SIG – Assisting the Development of Pathology in Low Resource Nations Saturday, 2030-2230 Chair: Indroit Roy, McGill University, Montreal, Quebec   A Volunteer Pathology Resident in Africa: a Jungle Adventure. Mona Alameldin, London Health Sciences Centre, Western University   Back to top     MONDAY, JULY 23   S2311 Hematological Pathology Symposium Monday, 0800-1030 Chair: Marciano Reis, Sunnybrook Health Sciences Centre and University Health Network, Toronto, Ontario 0800-0900 Bone Marrow Immunohistochemistry Emina Torlakovic, University Health Network, Toronto, Ontario Click here for Objectives of this session At the end of the session, the participants will be able to: •  Select most informative panels for work up of hematological neoplasms in the bone marrow; •  Apply quality control systems to bone marrow immunohistochemistry; •  Discuss tissue processing effects on the results of bone marrow immunohistochemistry testing. ------------------------------------------- 0900-0930 Refreshment Break 0930-1030 Update on Diagnostics and Prognostic Genetic and Molecular Aberrations in Myelodysplastic Syndromes (MDS), Towards a Standardized Approach Meer-Taher Shabani-Rad, Calgary Laboratory Service and University of Calgary, Calgary, Alberta Click here for Objectives of this session At the end of the session, the participants will be able to: •  Categorize and list the known genetic and molecular aberrations involved in pathogenesis of myelodysplastic syndro; •  Summarize and explain the latest technical methods developed for the diagnosis and prognostication of MDS; •  Discuss the future trends in the diagnosis of MDS with focus on aCGH (Array Comparative Genomic Hybridization) and SNP (Single Nucleotide Polymorphism). -------------------------------------------   Back to top     S2312 Canadian Society of Cytopathology Symposium and Kulcsar Lecture Monday, 0800-1030 Chair: Karim Khetani, University of Alberta, Calgary, Alberta 0800-0930 Kulscar Lecture: Technologic Advances Changing How We Practice Cytology – LBC, Automation, HPV, Lean-Sigma, What’s Cooking and What’s New? Dan Fontaine, Calgary Laboratory Services, Calgary, Alberta Ranjit Waghray, Calgary Laboratory Services, Calgary, Alberta Click here for Objectives of this session At the end of the session, the participants will be able to: •  Understand the impact of LBC and automation on the Gynecologic Cytology Laboratory; •  Know about the options for HPV testing and learn about available platforms; •  Be familiar with principles of Lean/Six Sigma and potential applications in the Cytology laboratory. ------------------------------------------- 0930-1000 Refreshment Break 1000-1030 Cytopathology Laboratories and the Alberta Cervical Cancer Screening Program (ACCSP) – A Recipe for Success Laura McDougall, Medical Lead, Alberta Breast and Cervical Cancer Screening Programs, Calgary, Alberta Click here for Objectives of this session At the end of the session, the participants will be able to: •  Describe the vital role of Cytopathology labs in organized cancer screening and their impact on increasing screening coverage; •  Illustrate the impact of revised clinical practice guidelines on lab utilization; •  Explain the joint effort required by public health and the laboratory in implementing HPV testing. -------------------------------------------   Back to top     S2321 Dr. Cam Coady Slide Seminar: Dermatopathology Monday, 1400-1700 Chair: Martin Trotter, Calgary Laboratory Services, Calgary, Alberta Presenters: Dermatopathology Section, Calgary Laboratory Services, University of Calgary   DIGITIZED IMAGES OF CASES FOR SLIDE SEMINAR ARE NOW AVAILABLE!   Go to this page for more information: http://www.pathologyconference.com/slideseminar12.htm     Click here for Objectives of this slide seminar At the end of the session, the participants will be able to: •  Diagnose twelve (12) important skin pathology diseases spanning inflammatory, infectious, neoplastic and infections conditions; •  Use the cases presented as triggers to review basic dermatopathology classification schemes and emerging concepts of skin diseases; •  Develop an approach to challenging skin pathology cases, including the use of ancillary testing and consultative second opinion. ------------------------------------------- 1400-1440 Duane Barber 1440-1520 Andrea Bruecks 1520-1545 Refreshment Break 1545-1625 Kelly Guggisberg 1625-1700 Martin Trotter   Back to top     TUESDAY, JULY 24   S2411 Anatomical Pathology Symposium Tuesday, 0800-1130 Chairs: Alan Spatz, Jewish General Hospital and McGill University, Montreal, Quebec; Sylvia Asa, University Health Network, Toronto, Ontario Click here for overview of this symposium This symposium will present the most recent advances in the molecular pathology of lung tumours, breast pathology, gynecological tumours, thyroid neoplasms and melanomas, in putting emphasis on the correlations between phenotypic findings and genotypic information. ------------------------------------------- Click here for Objectives of this symposium At the end of the session, the participants will: •  Better understand the recent discoveries made in the biology of these diseases; •  Improve their ability to prescribe appropriate molecular pathology tests; •  Better understand the current unmet needs and research orientation in these fields. ------------------------------------------- 0805-0840 Recent Advances in Lung Tumours Ming-Sound Tsao, Toronto General Hospital, Toronto, Ontario Click here for Objectives of this session At the end of the session, the participants will be able to: •  Recent changes in the classification of lung adenocarcinoma; •  Recent discoveries on oncogenic drivers in lung cancers and their therapeutic implications; •  Role of pathologists in the diagnosis and management of lung cancer. ------------------------------------------- 0840-0915 Recent Advances in Breast Pathology Anna Marie Mulligan, University Health Network, Toronto, Ontario Click here for Objectives of this session At the end of the session, the participants will be able to: •  Describe the current approach to the molecular classification of breast cancer; •  Compare the various multigene predictors currently available and how they relate to traditional prognostic parameters; •  Discuss the impact of molecular advancements on the management of patients with breast cancer. ------------------------------------------- 0915-0950 Recent Advances in Gynecological Tumours Blaise Clarke, University Health Network, Toronto, Ontario Click here for Objectives of this session At the end of the session, the participants will be able to: •  Recent developments in classification of ovarian cancer subtypes and molecular, prognostic, predictive and genetic predilection correlation with subtypes; •  Controversies in typing and grading of endometrial cancer and the role of the pathologist in identifying Lynch syndrome; •  Role and significance of HPV in vulvar squamous cell carcinoma. ------------------------------------------- 0950-1020 Refreshment Break 1020-1055 Recent Advances in Thyroid Neoplasms Sylvia Asa, University Health Network, Toronto, Ontario Click here for Objectives of this session At the end of the session, the participants will be able to: •  Understand the molecular changes that are associated with thyroid proliferative diseases; •  Describe the role of molecular testing in the diagnosis of thyroid nodules; •  Determine the impact of molecular testing on the management of patients with thyroid cancer. ------------------------------------------- 1055-1130 Recent Advances in Melanoma Alan Spatz, Jewish General Hospital and McGill University, Montreal, Quebec Click here for Objectives of this session At the end of the session, the participants will be able to: •  Better understand the recent discoveries made in the biology of melanoma; •  Improve their ability to prescribe appropriate molecular pathology tests; •  Better understand the current unmet needs and research orientation in the melanoma field. -------------------------------------------   Back to top     S2412 Pediatric and Perinatal Symposium Tuesday, 0800-1130 Chair: Fergall Magee, IWK Health Centre, Halifax, Nova Scotia Click here for overview of this symposium This symposium will offer a ‘state of the art’ update addressing aspects of pediatric cancer diagnosis. Attendees will review recent advances in the understanding of tumor biology and its impact on diagnostic and therapeutic algorithms, largely achieved through the efforts of the Children’s Oncology Group (COG). These efforts have resulted in more accurate diagnosis, the development of ‘novel’ agents, and a ‘risk stratification’ approach to therapy based on both patient and tumor signature. The session will present successes from the area of Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma and will highlight also the need for continued improvement by referring to cancer outcomes in adolescents and young adults [AYAs]. ------------------------------------------- 0800-0900 Acute Lymphoblastic Leukemia in the Pediatric Population Jason Ford, BC Childrens Hospital, Vancouver, British Columbia Click here for Objectives of this presentation At the end of the session, the participants will be able to: •  Summarize current concepts in the diagnosis and management of pediatric Acute Lymphoblastic Leukemias; •  Outline recent advances in the understanding of the molecular pathogenesis of pediatric acute lymphoblastic leukemia; •  Describe the significance of laboratory monitoring in pediatric ALL, including minimal residual disease testing by flow cytometry. ------------------------------------------- 0900-0930 Refreshment Break 0930-1030 Diagnosis and Therapeutic Approaches to Childhood Non-Hodgkin Lymphoma: Update from the Children’s Oncology Group Megan Lim, University of Michigan, Ann Arbour, Michigan Click here for Objectives of this presentation At the end of the session, the participants will be: •  Familiar with common types of NHL that occur in childhood and young adolescents; •  Familiar with recent advances in pathophysiologic mechanisms in childhood and young adolescent NHL; •  Familiar with Novel treatments for NHL in childhood and young adolescents. ------------------------------------------- 1030-1130 Cancer in Adolescents and Young Adults [AYAs] Fergall Magee, IWK Health Centre, Halifax, Nova Scotia Click here for Objectives of this presentation At the end of the session, the participants will: •  Understand the concept of Adolescent/Young Adult (AYA); •  Be aware of the epidemiology and unique biology of cancer in the AYA population; •  Be familiar of the specialized diagnostic requirements for this type of cancer and appreciate the impact this will have of health services. -------------------------------------------   Back to top     S2421 Advanced Diagnostics Symposium: Can We Afford Personalized Medicine? Tuesday, 1400-1700 Chair: David Lebrun, Queen’s University, Kingston, Ontario 1400-1410 Opening Remarks David LeBrun, Queen’s University, Kingston, Ontario 1410-1440 Personalized Medicine: The Limits of Predictive Genetics Risk Information Timothy Caulfield, Professor, Faculty of Law and School of Public Health, University of Alberta, Edmonton, Alberta Click here for Objectives of this presentation This presentation will provide a: •  Review of the current state of genetic risk information, particularly in the context of the direct-to-consumer testing industry; •  Analysis of legal and ethical challenges; •  Review of the potential impact of genetic risk information on healthy behavior change and public health systems. ------------------------------------------- 1440-1450 Questions and Discussion 1450-1520 Can We Afford Personalized Medicine? The Laboratory Perspective Suzanne Kamel-Reid, Princess Margaret Hospital, Toronto, Ontario Click here for Objectives of this presentation By the end of this session, the audience will have gained an appreciation of: •  The increased demand for molecular genetic test information for oncology clinical practice and the variety and complexity of the tests requested; •  The process a lab has to go through to validate a test for clinical implementation; •  The impact of new technology on the workflow and budgets of hospital labs; •  The impact of new technology on clinical reporting; is more information better? ------------------------------------------- 1520-1530 Questions and Discussion 1530-1540 Refreshment Break 1540-1610 Personalized Medicine: How Can We Not Afford It? A Clinical Perspective Paul Grundy, Senior Medical Director, Acting Vice President, Cancer Care for Alberta Health Services, Calgary, Alberta Click here for Objectives of this presentation At the end of the session, the participants will be able to: •  Understand “Personalized Medicine” in the perspective of the evolution of diagnostic and prognostic factors; •  Evaluate proposed new predictive tests with regard to clinical utility; •  Understand some of the administrative barriers to implementation of “Personalized Medicine”. ------------------------------------------- 1610-1620 Questions and Discussion 1620-1650 Pharmaceutical Funded Molecular Testing Model: Is this Sustainable? David Finlay, Senior Marketing Manager – Oncology, AstraZeneca, Mississauga, Ontario Click here for Objectives of this presentation At the end of the session, the participants will be able to: •  Provide the audience with a background of EGFR testing development in Canada; •  Ensure an understanding of how pharma (in this case AZ) has played a role in this process; •  Discuss the pros/cons of the sustainability of this model moving forward. ------------------------------------------- 1650-1700 Questions and Discussion   Back to top     S2422 Forensic Symposium Tuesday, 1400-1700 Chair: Michael Pollanen, University of Toronto and Office of the Chief Coroner of Ontario, Toronto, Ontario 1400-1630 Developing Sudden Death Investigation in Canada and the Place of Forensic Pathology John Butt, Pathfinder Forum Consulting Inc., Vancouver, British Columbia Click here for Objectives of this presentation At the end of the session, the participants will be able to: •  Explain the 20th century perspective on sudden death legislation/systems in Canada; •  Cite sustaining problems in developing changes to the above (1) including present day issues; •  Discuss and compare the problems and the needs for the change in the future of death investigation in our provinces and territories. -------------------------------------------   Back to top     S2423 Neuropathology Symposium Tuesday, 1400-1700 Chair: John Woulfe, Ottawa General Hospital, Ottawa, Ontario 1400-1515 How to Take Good Pathology Photographs Jeff Joseph, University of Calgary, Calgary, Alberta Click here for Objectives of this presentation At the end of the session, the participant will: •  Understand the importance of and be able to adjust a digital camera's exposure time, aperture, sensitivity, and white balance in order to optimize gross pathology photography; •  Apply some basic principles of composition to optimize gross photography; •  Examine a photograph's histogram and optimize or correct a photograph's colour; •  Use digital imaging software to optimize pathology photographs for different media (e.g. projection and printing). ------------------------------------------- 1515-1545 Refreshment Break 1545-1700 Perinatal Neuropathology: Common Acquired CNS Lesions and Malformations Lothar Resch, University of Calgary, Calgary, Alberta Click here for Objectives of this presentation At the end of the session, the participant will: •  Identify and diagnose the more common acquired perinatal CNS lesions and explain their pathogenesis; •  Identify and diagnose the more commons CNS malformations that present in the perinatal period and explain their pathogenesis. -------------------------------------------   Back to top     S2432 Pathology Education at Canadian Medical Schools: A Worrisome Diagnosis and a Potential Cure Tuesday, 1700-1745 Chair: Jason Ford, BC Childrens Hospital, Vancouver, British Columbia Click here for Objectives of this presentation At the end of the session, the participant will be able to: •  Describe the current place of pathology in undergraduate medical education in Canada, and the clinical consequences of pathology’s atrophied educational state; •  Explain the role of exit competencies in medical education; •  Develop appropriate exit competencies in pathology and laboratory medicine for MD students at their own institutions, and outline how these may be implemented. -------------------------------------------   Back to top             Banquet and Awards Presentations at the Glenbow Museum Tuesday, 1900-2200
CAP-ACP Conference Secretariat cap@eventsmgt.com Tel: 613.531.9210 Fax: 613.531.0626 4 Cataraqui Street, Suite 310 Kingston, ON K7K 1Z7
Annual Scientific Meeting of the Canadian Association of Pathologists Réunion annuelle scientifique de l’Association canadienne des pathologistes ©2011-2012 Events & Management Plus Inc. • Phone: (613) 531-9210 |  Fax: (613) 531-0626 | E-Mail: office@eventsmgt.com